This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Lynparza
  • /
  • Study on Olaparib Plus Abiraterone as First-line T...
Clinical trial

Study on Olaparib Plus Abiraterone as First-line Therapy in Men With Metastatic Castration-resistant Prostate Cancer

Read time: 3 mins
Last updated:31th Oct 2018
Identifier: NCT03732820
Register free for full access to medthority.com